A Phase 4 interventional study of Morphine Sulfate and Placebo in Pain, Postoperative, sponsored by Northwestern University. Recruiting at 1 site in United States. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-06-09.
Sponsored by Northwestern University · Phase 4, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 97 studies testing morphine in Pain, Postoperative — 18 open to participants now, 21 under way, 1 of them phase 3. Morphine · Pain, Postoperative.
Among the 97 studies testing morphine in Pain, Postoperative, this one is the 42nd largest by planned enrollment, is one of 4 that started in 2023, is one of 42 in phase 4, reaches primary completion later than 14 of the 20 other live ones, and was the 70th registered.
5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.
Browse Pain, Postoperative studies →18 of the 97 studies testing morphine in Pain, Postoperative are open now, in 11 countries. Recruiting first, the newest first:
Tanta University · Sites in Egypt
Ages 21–60
Sohag University · Sites in Egypt
Ages 18–60
Centre Hospitalier Universitaire, Amiens · Sites in France
Ages 18+
Ataturk University · Sites in Turkey
Ages 18–65 · Women only
Anne Juul Wikkelsø · Sites in Denmark
Ages 18+ · Women only
By country, each count listing its studies:
Morphine: first FDA approval 1984 (DURAMORPH PF). What it is approved for, and how studies give it, is on its page →
Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.
This study: 18 Years to 80 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
97 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 4 · Phase 2 15 · Phase 3 11 · Phase 4 42
First in 2001; this study’s year is marked. 4 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 90 is above the median of 75 across 4,859 interventional studies indexed under Pain, Postoperative.
Median enrollment 90 across the 97 interventional studies. Of the 60 that completed or were terminated, 14 (23%) have results posted.
This tab as a report to print or save as PDF → With an account.
7 of 97 have an industry lead sponsor. The 10 most frequent:
Northwestern University is the lead sponsor of 1,424 studies on the registry; 199 are open to participants now.
Of its 105 completed or terminated interventional studies of FDA-regulated products, 78 (74%) have results posted.
12 studies in Pain, Postoperative by Northwestern University: 4 open now, 4 under way, none of them phase 3. Of 5 finished, 4 (80%) have results posted.
Among the 12 studies in Pain, Postoperative by Northwestern University, this one is the 4th largest by planned enrollment, is one of 2 that started in 2023, is one of 6 in phase 4, and was the 10th registered.
Northwestern University’s Pain, Postoperative studies by the year they started, since 2010.
5 of the studies testing morphine in Pain, Postoperative that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07720739Sohag UniversityEfficacy of Adding Intrathecal Morphine to Erector Spinae Plane Block for Postoperative Analgesia After Midline Laparotomy | 2026-11 |
| NCT06761989Seoul National University HospitalIntrathecal Morphine Injection Versus Continuous Wound Infiltration After Pancreaticoduodenectomy | 2026-12-31 |
| NCT06797973Anne Juul WikkelsøEfficacy and Safety of Intrathecal Morphine for Postoperative Pain Management Following Planned Caesarean Section | 2027-05-31 |
| NCT05351229Northwestern UniversityIntrathecal Morphine for Analgesia in Video-assisted and Robotic-assisted Thoracic Surgery | 2027-06-01 |
| NCT07803133Erzincan Binali Yildirim UniversitesiPENG Block Versus Intrathecal Morphine for Early Postoperative Recovery After Total Hip Arthroplasty | 2027-09-01 |
Add all 5 to your calendar (.ics) → With an account.
Among the 97 studies testing morphine in Pain, Postoperative, from their registry updates:
Among Northwestern University’s 12 in Pain, Postoperative:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
VATS/RATS is widely used for diagnosis and treatment of intrathoracic conditions. Despite many benefits, postoperative pain continues to be intense after VATS/RATS. The optimal strategy for pain management has not been defined. In this randomized, placebo-controlled, double-blinded clinical investigation, investigators hypothesize that 5 mcg/kg intrathecal morphine will decrease postoperative analgesic consumption and reduce pain.
This is a randomized, placebo-controlled, double-blinded clinical trial. Patients will be randomized into one of two groups. Group A (Placebo, control group) will receive intrathecal sterile normal saline and Group B (Morphine group) will receive 5mcg/kg preservative free intrathecal morphine.
American Pain Society Outcome Questionnaire (APS-POQ) will be administered to patients prior to discharge (see data sheet).
Patients will be followed up with a phone survey at 1 and 3 months after surgery to assess the presence, nature, and severity of chronic persistent surgical pain. The Brief Pain Inventory is a reliable and valid measures of the interference of pain with physical functioning and will be used. Additionally patients will be asked about use of pain medications
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Placebo, Intrathecal saline
Other: Placebo
Intrathecal morphine
Drug: Morphine Sulfate
5 mcg/kg intrathecal preservative free morphine sulfate
Sterile saline, placebo
Also known as: Sterile Saline
Postoperative morphine equivalent consumption
Total MG of analgesic medications given converted to morphine
Time frame: 24 hours after surgery
Postoperative pain
Visual analog score between 0-10
Time frame: Up to 48 hours postoperative
Number of pain interventions
Number of times patient given medication for pain
Time frame: up to 48 hours postoperative
Postoperative opioid related side effects
Nausea medication administration, airway events, urinary retention, pruritus medication given,
Time frame: up to 48 hours postoperative
Self-reported patient satisfaction
American Pain Society Outcome Questionnaire
Time frame: prior to discharge from hospital, likely 1-3 days after surgery
pain qualities
pain intensity, location, quality via Brief Pain Inventory
Time frame: 1 month and 3 months after surgery
Self reported use of analgesic medications
Questions asked via phone call at 1 month and 3 months.
Time frame: 1 month and 3 months after surgery
self-reported limitation of daily activity at 1 and 3 months
Questions asked via phone call at 1 month and 3 months
Time frame: 1 month and 3 months after surgery
Plan to share: No — Not necessary to conduct study or data analysis
No publications or documents are linked to this record.
Started Sep 2023 (actual). Primary completion is estimated for Jun 2027, 44 months after the start.
Of 535 non-industry phase 4 interventional studies under Pain, Postoperative, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 32. This study's planned 44 months is above that.
Counting every sponsor, half of 545 studies reached it within 16 months; a quarter within 8 and three quarters within 32.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Morphine